Year
2026
-
RITM – 424B5
-
Rithm Capital Corp. Launches Public Offering of Preferred Stock
-
Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
-
Aon’s Latest GLP-1 Research Reveals Long-Term Employer Cost Savings and Significant Reductions in Cancer Risk for Women
-
U.S. Bancorp to Acquire BTIG
-
Fifth Third Bank Announces Redemption of Subordinated Bank Notes due March 15, 2026
-
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
-
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference
-
Non-Traditional Payment Method Acceptance and Customer Surcharges Grow Significantly at U.S. Small Businesses, J.D. Power Finds
-
Morningstar Launches New Managed Accounts Research Series and Defined Contribution Outcomes Model
-
FITB – 8-K
-
ENGIE and Ares Partnership Further Expands with Addition of 730 MW Portfolio of New U.S. Solar and Wind Assets
-
FITB – 424B2
-
Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
-
ASHFORD HOSPITALITY TRUST ANNOUNCES EXTENSION OF HIGHLAND LOAN AND SUSPENSION OF PREFERRED DIVIDENDS
-
Randall W. Atkins Appointed to National Coal Council
-
Trinity Capital Achieves Record $2.1 Billion of New Commitments and $1.5 Billion in Funded Investments in 2025
-
Southern Home Services Leading AI Adoption in the Trades By Harnessing the Power of ServiceTitan to Unlock Automation and Fuel Growth
-
TRIN – 8-K
-
USB – 8-K
-
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States
-
SLNH – 8-K
-
Delta Air Lines Orders up to 60 Boeing 787 Dreamliners to Grow, Modernize Widebody Fleet
-
JPMorganChase Reports Fourth-Quarter and Full-Year 2025 Financial Results
-
NXDT – UPLOAD [Cover]